Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1
Clinical trial NCT03502005 · COMPLETED
Trial details
- NCT number
- NCT03502005
- Sponsor
- Midland Research Group, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.